pyrazines has been researched along with Hemolysis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 4 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Green, ML; Jorga, K; Savic, RM; Tonda, M; Washington, CB | 1 |
| Abboud, MR; Brown, C; Campbell, A; Dixon, S; Estepp, JH; Griffin, NM; Inati, A; Inusa, BPD; Kalpatthi, R; Liem, RI; Piccone, C; Sims, K; Smith-Whitley, K; Tonda, M; Trompeter, S; Washington, C; Woods, G | 1 |
| Ferlis, M; Lipato, T; Roseff, SD; Smith, WR | 1 |
| Ataga, KI; Brugnara, C; Staffa, SJ; Stocker, JW | 1 |
| Hebbel, RP; Hedlund, BE | 1 |
| Abboud, MR; Achebe, MM; Alkindi, S; Ataga, KI; Brown, RC; Diuguid, DL; El-Beshlawy, A; Elghandour, A; Gordeuk, VR; Hassab, H; Hoppe, CC; Howard, J; Intondi, A; Kanter, J; Lehrer-Graiwer, J; Nduba, V; Telfer, P; Tonda, M; Tong, B; Tsitsikas, DA; Vichinsky, E; Ware, RE | 1 |
| Jiang, MY; Meng, Y; Shi, W; Song, HR; Wang, G | 1 |
| Beasley, FC; Dunman, PM; Heinrichs, DE; Magarvey, NA; Roux, CM; Wang, W; Wyatt, MA | 1 |
| Kim, JO; Li, G; Marasini, N; Quan, Q; Wei, L; Yong, CS | 1 |
| Janssens, BJ; Marchand-Brynaert, J; Rees, JF | 1 |
| Dubuisson, ML; Marchand-Brynaert, J; Rees, JF | 1 |
1 review(s) available for pyrazines and Hemolysis
| Article | Year |
|---|---|
Coelenterazine (marine bioluminescent substrate): a source of inspiration for the discovery of novel antioxidants.
Topics: Animals; Antioxidants; Drug Design; Hemolysis; Humans; Imidazoles; Lipid Peroxidation; Neuroprotective Agents; Oxidation-Reduction; Oxidative Stress; Peroxynitrous Acid; Pyrazines; Radiation-Protective Agents; Reactive Oxygen Species; Superoxides | 2005 |
1 trial(s) available for pyrazines and Hemolysis
| Article | Year |
|---|---|
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Antisickling Agents; Benzaldehydes; Biomarkers; Child; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Hemoglobin, Sickle; Hemoglobins; Hemolysis; Humans; Hydroxyurea; Intention to Treat Analysis; Male; Middle Aged; Polymerization; Pyrazines; Pyrazoles; Young Adult | 2019 |
9 other study(ies) available for pyrazines and Hemolysis
| Article | Year |
|---|---|
Model-informed drug development of voxelotor in sickle cell disease: Exposure-response analysis to support dosing and confirm mechanism of action.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Benzaldehydes; Drug Development; Hemoglobin, Sickle; Hemoglobins; Hemolysis; Humans; Pyrazines; Pyrazoles | 2022 |
Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years.
Topics: Anemia, Sickle Cell; Benzaldehydes; Biomarkers; Child; Child, Preschool; Female; Hemoglobin, Sickle; Hemolysis; Humans; Male; Pyrazines; Pyrazoles | 2022 |
Urgent use of voxelotor in sickle cell disease when immediate transfusion is not safe.
Topics: Anemia, Sickle Cell; Benzaldehydes; Blood Transfusion; Hemoglobin, Sickle; Hemolysis; Humans; Pyrazines; Pyrazoles; Transfusion Reaction | 2022 |
Haemoglobin response to senicapoc in patients with sickle cell disease: a re-analysis of the Phase III trial.
Topics: Acetamides; Anemia, Sickle Cell; Benzaldehydes; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Hemoglobins; Hemolysis; Humans; Hydroxyurea; Intermediate-Conductance Calcium-Activated Potassium Channels; Pyrazines; Pyrazoles; Trityl Compounds | 2021 |
Sickle hemoglobin oxygen affinity-shifting strategies have unequal cerebrovascular risks.
Topics: 2,3-Diphosphoglycerate; Anemia, Sickle Cell; Benzaldehydes; Cerebrovascular Circulation; Cerebrovascular Disorders; Erythrocytes, Abnormal; Hematocrit; Hematologic Agents; Hemoglobin, Sickle; Hemolysis; Humans; Hypoxia; Microcirculation; Models, Biological; Organ Specificity; Oxygen; Oxyhemoglobins; Polymerization; Protein Binding; Pyrazines; Pyrazoles; Risk Assessment | 2018 |
Cellular mechanisms of a new pyrazinone compound that induces apoptosis in SKOV-3 cells.
Topics: Acetamides; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Cycle; Cell Proliferation; Female; Flow Cytometry; Hemolysis; Humans; Ovarian Neoplasms; Pyrazines; Rabbits; Tumor Cells, Cultured | 2014 |
Staphylococcus aureus nonribosomal peptide secondary metabolites regulate virulence.
Topics: Amino Acid Sequence; Animals; Bacteremia; Dipeptides; Heart; Hemolysis; Liver; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Oligonucleotide Array Sequence Analysis; Peptide Biosynthesis, Nucleic Acid-Independent; Peptide Synthases; Pyrazines; Spleen; Staphylococcal Infections; Staphylococcus aureus; Virulence Factors | 2010 |
Development of ligustrazine-loaded lipid emulsion: formulation optimization, characterization and biodistribution.
Topics: Animals; Cells, Cultured; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Stability; Emulsions; Erythrocytes; Glycerol; Hemolysis; Lecithins; Male; Oleic Acid; Poloxamer; Pyrazines; Rabbits; Rats; Rats, Sprague-Dawley; Soybean Oil; Tissue Distribution | 2012 |
Protection of peroxide-treated fish erythrocytes by coelenterazine and coelenteramine.
Topics: Animals; Bass; Chromans; Comet Assay; DNA Damage; Dose-Response Relationship, Drug; Erythrocytes; Glutathione; Hemolysis; Imidazoles; Lipid Peroxidation; Oxidative Stress; Pyrazines; tert-Butylhydroperoxide; Thiobarbituric Acid Reactive Substances | 2002 |